These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3226575

  • 1. [Acute severe coronary insufficiency during intravenous therapy with buflomedil hydrochloride. Description of 4 cases].
    Romanò M, Spinelli A, Muzio L, Cazzani E, Baldini MR.
    Minerva Cardioangiol; 1988 Sep; 36(9):451-5. PubMed ID: 3226575
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H, Wehselau H.
    Med Welt; 1974 Jul 05; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract] [Full Text] [Related]

  • 6. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Jul 05; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G, Carre A, Ginestet A, Lambert M.
    Lille Med; 1976 Dec 05; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract] [Full Text] [Related]

  • 8. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun 15; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 11. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 Jun 15; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov 15; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 15; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Buflomedil: still too many fatal cardiac and neurological events.
    Prescrire Int; 2011 Apr 15; 20(115):99. PubMed ID: 21648214
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.